STRYVE FOODS INC-CLASS A (SNAX)

US8636852027 - Common Stock

0.648  +0 (+0.45%)

Fundamental Rating

1

Taking everything into account, SNAX scores 1 out of 10 in our fundamental rating. SNAX was compared to 90 industry peers in the Food Products industry. SNAX may be in some trouble as it scores bad on both profitability and health. SNAX is valued expensive and it does not seem to be growing.



0

1. Profitability

1.1 Basic Checks

SNAX had negative earnings in the past year.
SNAX had a negative operating cash flow in the past year.
In the past 5 years SNAX always reported negative net income.
SNAX had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -48.67%, SNAX is doing worse than 86.67% of the companies in the same industry.
Industry RankSector Rank
ROA -48.67%
ROE N/A
ROIC N/A
ROA(3y)-76.32%
ROA(5y)-83.27%
ROE(3y)-530.87%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

SNAX's Gross Margin of 19.67% is in line compared to the rest of the industry. SNAX outperforms 48.89% of its industry peers.
SNAX's Gross Margin has declined in the last couple of years.
SNAX does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 19.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.58%
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

SNAX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for SNAX has been reduced compared to 1 year ago.
The number of shares outstanding for SNAX has been reduced compared to 5 years ago.
The debt/assets ratio for SNAX is higher compared to a year ago.

2.2 Solvency

SNAX has an Altman-Z score of -7.63. This is a bad value and indicates that SNAX is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -7.63, SNAX is not doing good in the industry: 91.11% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.63
ROIC/WACCN/A
WACC13.36%

2.3 Liquidity

A Current Ratio of 0.38 indicates that SNAX may have some problems paying its short term obligations.
SNAX's Current ratio of 0.38 is on the low side compared to the rest of the industry. SNAX is outperformed by 94.44% of its industry peers.
A Quick Ratio of 0.17 indicates that SNAX may have some problems paying its short term obligations.
SNAX's Quick ratio of 0.17 is on the low side compared to the rest of the industry. SNAX is outperformed by 96.67% of its industry peers.
Industry RankSector Rank
Current Ratio 0.38
Quick Ratio 0.17

1

3. Growth

3.1 Past

SNAX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 39.98%, which is quite impressive.
Looking at the last year, SNAX shows a decrease in Revenue. The Revenue has decreased by -4.32% in the last year.
Measured over the past years, SNAX shows a small growth in Revenue. The Revenue has been growing by 1.37% on average per year.
EPS 1Y (TTM)39.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50.83%
Revenue 1Y (TTM)-4.32%
Revenue growth 3Y1.37%
Revenue growth 5YN/A
Sales Q2Q%36.39%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y47.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year14.09%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for SNAX. In the last year negative earnings were reported.
Also next year SNAX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for SNAX!.
Industry RankSector Rank
Dividend Yield N/A

STRYVE FOODS INC-CLASS A

NASDAQ:SNAX (12/20/2024, 8:00:02 PM)

0.648

+0 (+0.45%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-13 2024-11-13/amc
Earnings (Next)N/A N/A
Inst Owners9.3%
Inst Owner Change2.15%
Ins Owners32.72%
Ins Owner Change17.36%
Market Cap2.62M
Analysts82.86
Price Target4.08 (529.63%)
Short Float %2.09%
Short Ratio0.3
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.53%
Min EPS beat(2)13.61%
Max EPS beat(2)41.46%
EPS beat(4)4
Avg EPS beat(4)23.3%
Min EPS beat(4)4.96%
Max EPS beat(4)41.46%
EPS beat(8)7
Avg EPS beat(8)13.42%
EPS beat(12)9
Avg EPS beat(12)6%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)5.11%
Min Revenue beat(2)-10.73%
Max Revenue beat(2)20.95%
Revenue beat(4)2
Avg Revenue beat(4)-8.3%
Min Revenue beat(4)-43.49%
Max Revenue beat(4)20.95%
Revenue beat(8)2
Avg Revenue beat(8)-12.03%
Revenue beat(12)3
Avg Revenue beat(12)-12.78%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)22.22%
EPS NQ rev (3m)22.22%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)-32.4%
Revenue NQ rev (3m)-32.4%
Revenue NY rev (1m)-5.79%
Revenue NY rev (3m)-5.79%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.14
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-4.82
EYN/A
EPS(NY)-4.13
Fwd EYN/A
FCF(TTM)-1.52
FCFYN/A
OCF(TTM)-1.52
OCFYN/A
SpS4.78
BVpS-1.57
TBVpS-4.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -48.67%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 19.67%
FCFM N/A
ROA(3y)-76.32%
ROA(5y)-83.27%
ROE(3y)-530.87%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-26.58%
GM growth 5YN/A
F-Score4
Asset Turnover0.62
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1.28%
Cap/Sales 0.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.38
Quick Ratio 0.17
Altman-Z -7.63
F-Score4
WACC13.36%
ROIC/WACCN/A
Cap/Depr(3y)94.89%
Cap/Depr(5y)97.43%
Cap/Sales(3y)5.97%
Cap/Sales(5y)7.27%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.98%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%50.83%
EPS Next Y47.24%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.32%
Revenue growth 3Y1.37%
Revenue growth 5YN/A
Sales Q2Q%36.39%
Revenue Next Year14.09%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y24.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year53.07%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y84.26%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y82.95%
OCF growth 3YN/A
OCF growth 5YN/A